Superparamagnetic iron oxide nanoparticles as radiosensitizer via enhanced reactive oxygen species formation.

Internalization of citrate-coated and uncoated superparamagnetic iron oxide nanoparticles by human breast cancer (MCF-7) cells was verified by transmission electron microscopy imaging. Cytotoxicity studies employing metabolic and trypan blue assays manifested their excellent biocompatibility. The production of reactive oxygen species in iron oxide nanoparticle loaded MCF-7 cells was explained to originate from both, the release of iron ions and their catalytically active surfaces. Both initiate the Fenton and Haber-Weiss reaction. Additional oxidative stress caused by X-ray irradiation of MCF-7 cells was attributed to the increase of catalytically active iron oxide nanoparticle surfaces.

[1]  Petras Juzenas,et al.  Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. , 2008, Advanced drug delivery reviews.

[2]  T. Xia,et al.  Toxic Potential of Materials at the Nanolevel , 2006, Science.

[3]  C. Beaumont,et al.  Iron metabolism, free radicals, and oxidative injury. , 2001, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  Barry Halliwell,et al.  DNA damage by oxygen‐derived species Its mechanism and measurement in mammalian systems , 1991, FEBS letters.

[5]  Jerry S. H. Lee,et al.  Magnetic nanoparticles in MR imaging and drug delivery. , 2008, Advanced drug delivery reviews.

[6]  L. Juillerat-Jeanneret,et al.  Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. , 2005, Biomaterials.

[7]  R. Massart,et al.  Preparation of aqueous magnetic liquids in alkaline and acidic media , 1981 .

[8]  Nastassja A. Lewinski,et al.  Cytotoxicity of nanoparticles. , 2008, Small.

[9]  Morteza Mahmoudi,et al.  A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles. , 2010, Colloids and surfaces. B, Biointerfaces.

[10]  É. Duguet,et al.  Magnetic nanoparticle design for medical diagnosis and therapy , 2004 .

[11]  A. Smirnov,et al.  Surface-mediated production of hydroxyl radicals as a mechanism of iron oxide nanoparticle biotoxicity. , 2011, Journal of the American Chemical Society.

[12]  Armand Masion,et al.  Relation between the redox state of iron-based nanoparticles and their cytotoxicity toward Escherichia coli. , 2008, Environmental science & technology.

[13]  Q. Pankhurst,et al.  Applications of magnetic nanoparticles in biomedicine , 2003 .

[14]  C Alexiou,et al.  Clinical applications of magnetic drug targeting. , 2001, The Journal of surgical research.

[15]  Sangjin Park,et al.  Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. , 2008, Angewandte Chemie.

[16]  Thomas J. Meade,et al.  Multimodal MRI contrast agents , 2007, JBIC Journal of Biological Inorganic Chemistry.

[17]  R Weissleder,et al.  Superparamagnetic iron oxide: pharmacokinetics and toxicity. , 1989, AJR. American journal of roentgenology.

[18]  Haiou Qu,et al.  Water-dispersible iron oxide magnetic nanoparticles with versatile surface functionalities. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[19]  C. Bárcena,et al.  APPLICATIONS OF MAGNETIC NANOPARTICLES IN BIOMEDICINE , 2003 .

[20]  Heather Kalish,et al.  Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. , 2003, Radiology.

[21]  Martin Frenz,et al.  Metabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo study , 2011, International journal of nanomedicine.

[22]  T. Webster,et al.  Magnetic nanoparticles: biomedical applications and challenges , 2010 .

[23]  Tae-Jong Yoon,et al.  Toxicity and tissue distribution of magnetic nanoparticles in mice. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.